Long-Term Follow-Up of a Glucocorticoid Minimizing Regimen for the Treatment of Severe Antineutrophil Cytoplasmic Autoantibody–Associated Vasculitis
Ultrarapid GC withdrawal is safe and effective for many patients with AAV when used with combination induction regimens. This approach warrants confirmatory controlled studies and may have a place in the current management of patients at high risk of GC toxicities.
Authors
- Marie Condon (ORCID: https://orcid.org/0000-0001-7974-013X)
- Alan David Salama (ORCID: https://orcid.org/0000-0002-9255-9092)
- Tony Lopez (ORCID: https://orcid.org/0000-0002-3376-5371)
- Sally Hamour
- Megan Griffith (ORCID: https://orcid.org/0000-0001-8261-1216)
- Maria Prendecki (ORCID: https://orcid.org/0000-0001-7048-7457)
- Tom Cairns
- Jeremy Levy (ORCID: https://orcid.org/0000-0001-7498-6413)
- Stephen P. McAdoo (ORCID: https://orcid.org/0000-0001-8260-8770)
- Amrita Dhutia (ORCID: https://orcid.org/0000-0001-5154-7039)
- Charles D. Pusey (ORCID: https://orcid.org/0000-0002-1424-3906)
- Mark A. Little (ORCID: https://orcid.org/0000-0001-6003-397X)
- Ruth J. Pepper
- Áine Burns
Institutions
- Imperial College Healthcare NHS Trust (GB)
- Royal Free London NHS Foundation Trust (GB)
- Hammersmith Hospital (GB)
- Tallaght University Hospital (IE)
- University College London (GB)
- Imperial College London (GB)
Publication Details
- Journal
- Kidney International Reports
- Published
- 2025-03-11
- DOI
- https://doi.org/10.1016/j.ekir.2025.03.009
- Citations
- 5
- Primary Topic
- Vasculitis and related conditions
- Type
- article
- Field-Weighted Citation Impact
- 7.59
Funders
- NIHR Imperial Biomedical Research Centre